As a former, pharma disttrict manager and formerly rep i can testify that any tiny drop in sales will be due to the sales force taking off their week, sometimes 2 week vacation in july/august, thats when every rep takes a week off.. FACT!!!!
As of June 30, 2017, Da Vita Kidney Care operated or provided administrative services at 2,445 outpatient dialysis centers located in the United States serving approximately 194,600 patients. The company also operated 217 outpatient dialysis centers located in 11/12? Countries outside the United States. I searched the international and each of the countries web pages. The countries are Brazil, (12 centers), China (? centers)), Columbia (19 centers), Germany (27 centers), India ((9 cities with multiple locations), Malaysia (38 centers), Netherlands (? centers), Poland (52 centers), Portugal (5 centers), Saudi Arabia (20 centers) Singapore (1 center), and Taiwan (5 centers). KERX made a presentation at “THE WORLD CONGRESS OF NEPHROLOGY” on 04/23/2017. I don’t understand why KERX is no partnering with Da Vita at these locations in particular with the 2 Latin America countries, the 4 European countries, India and Saudi Arabia. Just think the impact in sales if we could get “our foot in the door” of these countries. We need all the owners of KERX stock call every day KERX investor relations office to ask this question. Also we need to do the same during the next press conference.
BO will happen before Nov.
I've been in this stock for over 4 years, always adding in dribs and drabs. Those of you who think I'm a short or a basher can stick it up your #$%$ or you can come on down to Spring Hill FL and I'll stick it up your #$%$ for you.
My guess for price action..... insiders know scripts are trending up again. Just a guess but I think week 33 script number will be 1100. We'll see. Jwjone
Field sales foot off the pedal. Not sure why. Scripts should be compounding big time at this point. I'm going to take the glass half full view point and speculate that BO speculation has impacted the field sales in terms of turnover and intensity. Home office might not be totally focused right now. If they were why does Bow Tie Tony still have a job. I feel BO is in sight. Maybe real soon based on the bog players who jumped in.
BO speculation in NO way negatively impacts sales. If managed and incentivized properly the KERK sales team, marketing team, and management should be in lockstep focused on increasing scripts above all else. They appear to have done a very good job getting insurance/payers on board and did all they can to set themselves up for a favorable decision late Oct-early Nov. There is NO excuse for sales to be slacking... they should have plenty of wind in their sails and be growing the sales forecasts so they fly into NOV. AND they can't let up going into the holidays. Treat every end of month like it ends on the 25th and like its the end of their fiscal year... this includes 11/20 and 12/20 as holidays approach. If there is a BO, odds are in is announced before YE17 or no Q118. SO THE SALES MUST keep rising to help the valuation.
KERX won't be in the mid 6's next summer! $10 to $15! Now is the time to buy or add to your position if you have funds available.
IMS # 941 per dough on Stock Twits.
SLNO (MC $16 M) BLOCKBUSTER in Phase 3 /Rare Disease & Orphan Status = REAL Unknown low float stock with 1000% upside Potential and more .Next billion dollar rare disease company like SRPT here .GLTA
Soleno therapeutics (SLNO)
Market Cap $16 Million Cash: $8 Million Price $0.35
Shares Out: 47.6 Million ( 36 Million shares held by Insiders & Institutions)
•Company expects to initiate pivotal Phase III clinical trial by year-end 2017; will take approximately 9-12 months to complete
Soleno Therapeutics, Inc. (Soleno) is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company is currently advancing its lead candidate, DCCR, a once-daily oral tablet for the treatment of PWS, into a Phase III clinical development program at the end of 2017.
Market Opportunity for PWS is Substantial.
While the lack of approved treatments for PWS alone make it difficult to assess the market, sales of Pfizer’s (NYSE: PFE) Genotrop in (somatropin) can provide some insight despite being indicate for PWS, in addition to, growth failure due to growth hormone deficiency(GHD),Turner syndrome,idiopathic short stature,and small for gestational age.This product achieved its highest revenue in 2008,with worldwide sales of approximately $900 million.While somatropin has been proven to improve growth and body composition, it does not affect the key disease component of hyperphagia and use is associated with substantial risk. Soleno is developing DCCR for the treatment of PWS,to help address the unmet need of this patient population. To assess the potential of DCCR for PWS, we performed a scenario analysis, which indicates that annual sales could be in the range of $1.1 billion given a moderate price point and 50% market penetrance.
low volume.. No sellers . good sign.
Consonance Capital- 7,000,000+ new shares @ 6/31
Please post IMS script number when you get it. Thanks. jwjone
Moving right in line with the index in the absence of news
Same old sht, up 2 days then down 2-3 days. All the gain is gone.
Steve Cohen's Point72 Asset Mgmt....Increases their KERX holdings by 1,452.700.....Now holds 1.552,700.....
Script numbers anyone ??? Thanks
How many times are we going to crossover 6.66. let us now see 7.77 and on our way to 10's and 20's. Tired of back and forth of this stock . lots of manipulation going on.
Every day I come to yahoo finance I think yahoo is looking more and more like a SJW site. Just a matter of time and I will find a different place for my info on stocks.
Bet even the SJW's are irritated. Since they wont be able to agree on what bothers them the most or hurt their feelings today.
And Otiv stock on here is really badly ran over with sjw's.
Thinking I will be finding a new home for info
Can someone give a good theory as to why there are over 800 Aug 8 puts bought? Just a Hedge for a bigger short position?